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Recent studies have indicated a critical role for interferon (IFN)-mediated antiviral responses in the host range of myxoma virus (MV), a
pathogenic poxvirus of rabbits. To investigate the contribution of IFN to MV tropism in nonleporine cells, primary human dermal fibroblasts
(HDFs) were tested for permissiveness to MV infection. Low-passage HDFs that underwent fewer than 25 population doublings (PD) were
fully permissive for MV infection, supporting productive virus replication and cell-to-cell spread. In contrast, early and late viral gene
expression was detectable in high-passage HDF (N75 PD), but MV failed to generate infectious progeny and could not form foci in these
cells. Vesicular stomatitis virus (VSV) plaque reduction assays confirmed that constitutive IFN production progressively increased as HDFs
were passaged, concurrent with an increase in the expression of transcripts for type I IFN and IFN-responsive genes involved in antiviral
responses. These findings correlated with the enhanced sensitivity of higher-passage HDF to inducers of type I IFN responses, such as
dsRNA. Furthermore, pretreatment of low-passage HDF with type I IFN abrogated MV spread and replication while treatment of mature
HDF with neutralizing antibodies to IFN-h, but not IFN-a, restored the capacity to form foci. These findings emphasize the importance of
post-entry events in determining the permissiveness of human cells to MV infection and support a critical role for innate type I IFN responses
as key determinants of poxvirus host range and species restriction.
D 2004 Elsevier Inc. All rights reserved.
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Myxoma virus (MV) is a leporipoxvirus that is the
causative agent of myxomatosis, a lethal disease of European
rabbits that presents with extensive fulminating lesions,
immune dysfunction, and secondary bacterial infections of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Canada C1A 5T1.the respiratory tract (Fenner and Ratcliffe, 1965). Although
MV exhibits strict species specificity for the rabbit and is
nonpathogenic in other vertebrates, growing evidence
indicates that MV can productively infect cells from diverse
species in vitro. For example, MV has been recently shown
to replicate in select murine cells (Johnston et al., 2003), as
well as a broad spectrum of human tumor cell lines (Sypula
et al., 2004). For most pathogens, the requirement for
species-specific cell surface receptors that mediate virus
entry is a critical determinant of host range (Mims, 1989;
Schneider-Schaulies, 2000). However, no specific host cell
receptor has ever been identified as being obligatory for
infection by any poxvirus (Moss, 2001), suggesting that
virus–host interactions that follow adsorption and entry of
target cells determine permissiveness to poxvirus infection.05) 235–248
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presence of vigorous host immunity by employing
numerous strategies to evade, obstruct, or subvert elements
that mediate antiviral responses to infection (Kerr and
McFadden, 2002; Seet et al., 2003). In addition to sharing
the ultimate goal of creating an intracellular environment
that promotes productive virus infection, a central compo-
nent of many of these strategies is the ability to manipulate
cell signaling pathways critical to host antiviral responses
(Greber, 2002). For example, MV infection rapidly
activates kinase-mediated signal transduction that facili-
tates downstream events leading to productive infection
(Johnston et al., 2003; Masters et al., 2001), inhibition of
which renders cells nonpermissive (Johnston et al., 2003;
Lalani et al., 1999). More recently, MV has also been
shown to target signaling pathways involving nuclear
factor (NF)-nB (Camus-Bouclainville et al., 2004).
Although the actions of many of the immunomodulatory
proteins encoded by MV are dispensable for replication in
culture, they are often essential for replication within the
host (Kerr and McFadden, 2002). Thus, the pathways
targeted by MV to manipulate innate and adaptive host
defense mechanisms have important consequences for viral
tropism and the pathogenic effects of viral infections and
may provide insight into the molecular mechanisms
underlying poxvirus host range.
Recently, host antiviral responses mediated by type I
interferon (IFN), which includes IFNa and IFNh (Lau and
Horvath, 2002), have been implicated as key determinants
of the restrictive host range exhibited by MV in murine cells
(Wang et al., 2004). Infected cells are likely capable of
multiple response pathways to induce type I interferon-
regulated genes, but it is believed that the virus–host tug-of-
war is exerted in particular at the level of interferon
regulatory factor (IRF)-3 activation, which is one of the
key regulators of IFN-h gene expression (reviewed in
Barnes et al., 2002; Levy et al., 2003; Malmgaard, 2004;
Servant et al., 2002; Williams and Sen, 2003). If type I IFN
is produced as a consequence of virus infection, the ligand is
released into the extracellular milieu where it acts in both an
autocrine and a paracrine fashion, binding to specific
receptors on the surface of both infected and uninfected
cells. This interaction activates signaling cascades, such as
the signal transducer and activator of transcription (STAT)-
janus kinase (JAK) pathway, leading to the expression of
interferon-responsive genes. The activity of the resulting
gene products promotes an antiviral state that decreases the
susceptibility of uninfected cells to subsequent infection and
impedes virus spread.
In fact, the actions of IFN are so effective at controlling
the spread of viruses that all poxviruses employ at least one
mechanism to disrupt their activity (Seet et al., 2003). These
mechanisms primarily target host responses activated by
dsRNA produced within infected cells during virus tran-
scription, such as the IFN-dependent enzymatic cascades
mediated by double-stranded RNA (dsRNA)-dependentprotein kinase R (PKR) and the 2V,5V-oligoadenylate
synthetase (OAS) (reviewed in Katze et al., 2002; Malm-
gaard, 2004; Taniguchi and Takaoka, 2002; Williams and
Sen, 2003). PKR and OAS regulate response pathways that
impede viral replication at multiple levels, promoting cell
cycle arrest, a shutdown of host and virus protein synthesis
and apoptosis. In an effort to inhibit these pathways, MV is
predicted to encode a competitively inhibiting structural
mimic of eukaryotic initiation factor (eIF)-2a, a substrate of
PKR that induces growth arrest (Ramelot et al., 2002), as
well as a dsRNA binding protein (Barrett et al., 2001).
However, the exact mechanism of action for these proteins
remains unclear.
In the current study, primary human dermal fibroblasts
(HDFs) derived from neonatal foreskin explants were used
to further investigate the contribution of type I IFN to MV
host range and cell tropism. Neonatal HDFs initially exhibit
decreased basal level IFN activity following explantation
that increases with progressive population doublings (PD)
as cells are passaged in vitro, a process commonly used as a
model for cellular aging and the progression toward
senescence (Komatsu et al., 1981; St. Geme and Horrigan,
1969). This progression manifests with increased type I IFN
production, elevated levels of transcripts for IFN-responsive
genes, and increased sensitivity to inducers of type I IFN
responses. Of note, these properties are not unique to human
fibroblasts, and similar responses have been reported for
fibroblasts from other species, such as chick embryo
fibroblasts (Lockart, 1968; Marcus and Carver, 1967) and
murine L-cells (Jordan and Merigan, 1974).
Consistent with a critical role for IFN responses as
determinants of MV host tropism, we report that primary
HDFs are initially permissive to MV replication, but become
refractory to MV infection with repeated passaging in
culture. This loss of permissiveness correlates with
increased basal levels of IFN activity in high-passage
HDF compared to low-passage cells and can be completely
reversed by inhibiting host IFN responses. These findings
emphasize the importance of early events following
recognition and entry of target cells in determining
permissiveness to poxvirus infection and suggest a major
role for IFN responses in the maintenance of the species
barrier exhibited by many poxviruses.Results
Human dermal explant cultures are permissive to MV
infection
Primary HDFs were selected as a model system for
these studies for several reasons. First, virus-enriched
discharge from skin lesions that characterize MV infection
of rabbits supports transmission of the virus by direct
contact with an infected host, or more typically, via
arthropod vectors such as the mosquito (Fenner and
J.B. Johnston et al. / Virology 332 (2005) 235–248 237Ratcliffe, 1965). Consequently, fibroblasts within the
dermis are among the first cell types initially colonized
by MV at the primary site of infection before it is
disseminated to peripheral tissues. Second, transformed
fibroblasts from several species, including human and
nonhuman primate, murine, avian, and feline cells, have
been found to support MV replication in vitro (Comanita
and Dekaban, 2004; Johnston et al., 2003; Lalani et al.,
1999; Sypula et al., 2004). Finally, changes in host IFN
responses following aging in culture have been well
documented for primary fibroblasts (Jordan and Merigan,
1974; St. Geme and Horrigan, 1969). Thus, the effects on
MV replication of changes in constitutive IFN activity and
responsiveness could be assessed in a naturally developing
system using cells derived from the same donor.
The block to MV replication in nonpermissive cells most
commonly manifests as the failure to progress through viral
DNA synthesis to the late gene expression necessary to
produce progeny virions, despite normal virus binding,
entry, and early gene expression (Johnston et al., 2003). To
determine if MV could infect primary human dermal cells,
explants from neonatal foreskin tissue were prepared and
allowed to adhere to culture dishes to stimulate cell
outgrowth. Proliferating cells, initially classified as either
fibroblast (HDF) or epithelial cells (HEP) on the basis of
morphology, were typically observed after 5 days in culture
and formed intact cell monolayers by 21 days (Figs. 1A
and E). Outgrowth cultures were then infected at an
multiplicity of infection (MOI) = 1 with either vMyxgfp
(Figs. 1B–F) or vMyxlac (Figs. 1G and H) and viral
replication was assessed at various time points PI by
fluorescence microscopy or h-galactosidase assay, respec-
tively. Green fluorescent protein (GFP) fluorescence was
detected in both the explant and individual cells within
HDF monolayers at 16 h PI (Fig. 1B), suggesting that these
cells supported virus entry and early gene expression.
Moreover, MV exhibited the capacity to spread and
replicate within the monolayer, giving rise to large foci at
40 h (Fig. 1C) and 60 h (Fig. 1D) PI. Early gene expression
was also evident in HEP cultures infected with vMyxgfp
(Fig. 1F), although less viral spread was observed
compared to HDF. Detection of h-galactosidase activity
and foci formation at 40 h (Fig. 1E) and 60 h (Fig. 1F)
following infection of HDF with vMyxlac further supported
the capacity for MV to replicate and spread within these
cells. To confirm that the GFP and h-galactosidase
expression detected in MV-infected HDF was evidence of
viral protein synthesis, the expression of representative
early and late MV proteins was assessed by Western blot
analyses at 6 and 16 h PI. Expression of both the early
protein M-T7 (Fig. 1I), and the late protein Serp-1 (Fig. 1J)
was detected in HDF and HEP following MV infection.
These findings demonstrated that there was no block to MV
entry, early or late gene expression, or DNA synthesis in
primary human dermal cells. Moreover, similar results were
obtained using HDF obtained from multiple donors.Primary HDFs are permissive to MV replication
The foci formation observed in MV-infected human
dermal cell cultures suggested that progeny virions were
both being produced and spreading to adjacent cells within
the monolayer. To determine if these cells were in fact
permissive to MV replication, rapidly replicating HDFs
were isolated from slowly replicating HEP cells and the
purity of each cell population confirmed by RT-PCR
detection of fibroblast-specific markers (data not shown).
Single-step growth curves (Fig. 2A), for which cells were
infected at high MOI to provide insight into MV
replication at the single-cell level, and multistep growth
curves (Fig. 2B), for which cells were infected at low MOI
to assess replication and spread within a population of
cells, were then generated for each cell type. As shown in
Fig. 2, primary HDFs were fully permissive to MV
infection and supported the production of progeny virions
following infection at both high and low MOI. Moreover,
single-step growth curves indicated that HDF supported
MV replication at levels comparable to primary rabbit
dermal fibroblasts (RDF) (Fig. 2A). In contrast, despite the
ability to detect both early and late viral gene expression,
MV was unable to generate progeny virus in HEP cells
regardless of MOI. For both single- and multistep curves,
the viral titers obtained from HEP cells did not signifi-
cantly exceed the input titer of the original inoculum.
These findings represent the first report of the productive
infection of a primary human cell line by MV and indicate
that this capacity is cell type dependent. In addition, these
findings indicated that there was no fundamental block to
MV replication in primary HDF once viral entry had
occurred, provided that the IFN response is not engaged.
High-passage HDFs fail to support MV replication
Since HEP cells did not support productive MV
replication, subsequent experiments focused on MV infec-
tion of primary HDF. However, attempts to investigate the
molecular mechanism underlying the permissiveness of
HDF to MV infection revealed an interesting and reprodu-
cible trend. As shown in Figs. 3A and B, HDFs that were
passaged fewer than five times, corresponding to approx-
imately 25 population doublings (PD), remained fully
permissive to MV infection. As with the explant cultures
from which these cells were derived, MV infection of low-
passage HDF resulted in abundant h-galactosidase activity
(Fig. 3E) and led to the production of infectious progeny
virions (Fig. 3F). In contrast, cells that were repeatedly
passaged (Figs. 3C and D) gradually became progressively
resistant to MV infection until foci formation was no longer
detectable after passage 10 (approximately 50 PD). Loss of
foci formation was accompanied by decreased h-galactosi-
dase activity (Fig. 3E) and the inability to support a
productive infection (Fig. 3F). In comparison, little differ-
ence in viral titers and h-galactosidase activity was
Fig. 1. MV infection of primary HDF. Three-week-old HDF and HEP explant cultures were infected with MVat MOI = 1 and assessed for viral replication and
viral gene expression at various times PI. The explants from which cells originated are indicated by an arrow. (A–D) Fluorescence microscopy detection of
HDF infected with vMyxgfp at 16 h (B), 40 h (C), and 60 h (D) PI. A representative brightfield micrograph is shown (A). (E and F) Brightfield (E) and
fluorescence (F) microscopy detection of HEP infected with vMyxgfp. (G and H) h-Galactosidase staining of vMyxlac-infected HDF at 40 h (G) and 60 h (H)
PI. (I and J) Western blot detection of the expression of representative early (M-T7) and late (Serp-1) MV genes. Detection of secreted Serp-1 in culture
supernatants from HDF collected at 16 h PI is shown (S16).
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(Figs. 3E and F). Early gene expression was still detectable
in both high- and low-passage HDF by fluorescence
microscopy following infection with vMyxgfp (Figs. 3A–
D, insets) and by Western blot detection of M-T7
expression (Fig. 3G). However, GFP expression wasdecreased in high-passage HDF and the late MV protein
Serp-1 was not immediately observed in lysates from P5
and P10 cultures (Fig. 3G). Since h-galactosidase activity
was still evident in the sporadic foci evident in P5 HDF
(Fig. 3C) and as individual positive cells in P10 cultures
(Fig. 3D), it is likely that Serp-1 levels were sufficiently
Fig. 2. MV infection of primary HDF is productive. HDF, HEP, and RDF
were infected with vMyxlac and viral replication assessed by titration of
infectious progeny on BGMK cells. Titers at each time point represent the
mean focus forming units F standard deviation (SD) from triplicate wells.
(A) Single-step growth curve derived from low-passage cells infected at
MOI = 5. (B) Multistep growth curve derived from low passage cells
infected at MOI = 0.1
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Consistent with this hypothesis, and similar to MV-infected
HEP cells, overexposure of the blots shown in Fig. 3H did
reveal low-level Serp-1 expression (data not shown). These
findings suggest that repeated passage of primary HDF in
vitro promoted the development of an antiviral state
refractory to sustained MV replication. Moreover, the block
to MV replication did not simply represent failure to
progress to late MV gene expression but appeared to reflect
a decreased capacity to spread within the monolayer and
form foci.
High-passage HDFs exhibit enhanced sensitivity to dsRNA
In an effort to determine the mechanism underlying the
loss of permissiveness associated with sustained passage,
we first addressed the question of whether MV infection of
high-passage HDF was cytotoxic. For these studies, P1 and
P10 HDFs were infected with MV at different MOI and cell
viability was assessed by trypan blue exclusion assay at 12 h
PI. Although minimal differences were observed between
low- and high-passage HDF infected at MOI = 0.1, cell
death was significantly increased in P10 cells infected at
MOI = 5 compared to P1 HDF (Fig. 4A). A similar patternwas observed when parallel HDF cultures were analyzed by
flow cytometry following staining with Annexin V to detect
cells actively undergoing apoptosis. Infection of P10 HDF
with MV at high multiplicities induced an apoptotic
response that was not evident in MV-infected P1 HDF
cultures (Fig. 4B). Again, no differences were observed
when cells were infected at MOI = 0.1 (Fig. 4B).
To further dissect this process, we next tested the
sensitivity of high- and low-passage HDF to various stress
stimuli associated with cell cycle arrest. As with low
multiplicity infections, similar levels of cell death and
apoptosis were detected in both high- and low-passage
HDFs subjected to serum deprivation and treatment with
pro-apoptotic drugs that inhibit proteasome (LLnL) or
protein kinase C (staurosporine, STS) activity (Figs. 4A
and B). However, high-passage HDFs were approximately
2.5-fold more sensitive than low-passage cells to the
cytotoxic effects of poly(I:C) dsRNA, a by-product of viral
transcription that induces host IFN responses in infected
cells (Tamura and Sasakawa, 1983). Taken together, these
findings indicated that the loss of permissiveness exhibited
by high-passage HDF could be attributed, at least in part, to
accelerated cell death following MV infection. Moreover,
this property was associated with increased sensitivity to the
inhibitory effects of dsRNA.
The IFN response pathway is constitutively activated in
high-passage HDF
The observation that high-passage HDFs were more
sensitive than low-passage cells to dsRNA implicated host
IFN responses as potential determinant of the loss of
permissiveness exhibited by primary HDF following
passaging. This hypothesis was further supported by the
finding that individual high-passage HDFs were permis-
sive to MV infection, although the infection was abortive
due to a cytotoxic response, but that MV was unable to
spread to adjacent cells within the monolayer (Fig. 3). As
detailed above, Type I IFN acts to limit infections by
promoting both clearance of infected cells and the
development of an antiviral state in uninfected cells that
impedes virus spread.
To determine at which level IFN responses were altered,
HDFs of varying passage histories were cultured for 24 h
and protein, RNA, and conditioned medium (CM) harvested
for subsequent analysis. RT-PCR detection of IFN-h tran-
scripts revealed that constitutive IFN expression increased
as HDFs were passaged, such that IFN-h was not detectable
in low-passage HDF but was abundantly expressed in P10
cells at levels comparable to that found in P1 HDF
stimulated with dsRNA (Fig. 5A). Moreover, the expression
of elements within the IFN response pathway, such as PKR
and OAS, exhibited a similar profile. PKR and OAS were
constitutively expressed at higher levels in P10 HDF than
P1 HDF (Fig. 5A). Western blot analyses of other elements
within the IFN response pathway, such as PKR and its
Fig. 3. Loss of permissiveness to MV infection with repeated passaging of HDF. HDF (clone A9) and RDF (clone A1) were cultured for the indicated number
of passages (one passage represents five population doublings) prior to being infected with vMyxlacZ at MOI = 1. (A–D) HDF cultures were passaged 1
(A, P1), 3 (B, P3), 5 (C, P5), or 10 (D, P10) times and infected with vMyxlac at MOI = 1. Foci were detected by h-galactosidase staining at 48 h PI.
Parallel HDF cultures were infected with vMyxgfp (insets) and early viral gene expression visualized by fluorescence microscopy. (E) Quantification of the
level of h-galactosidase expression at 48 h PI of HDF and RDF cultures. Values represent mean absorbance F SD (corrected for background) from
triplicate wells with mock-infected cells as a control. (F) Viral titers obtained at 48 h PI of HDF and RDF. Values represent mean focus forming units F SD
from triplicate wells. (G) Western blot detection of early (M-T7) and late (Serp-1) MV gene expression following vMyxlac infection of passaged HDF.
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yielded similar results. As suggested by RT-PCR, PKR was
detectable by Western blot in virtually all HDF cultures
regardless of passage history (Fig. 5B). Activated PKR
phosphorylated on Thr457, however, was only detected in
high-passage HDF in the absence of exogenous stimuli.
Recent evidence has shown that PKR can be activated
independent of dsRNA by cellular regulators, such as
PACT, which interact with the enzyme through its
dsRNA-binding motifs and enhance phosphorylation ofeIF-2a (Patel and Sen, 1998). The stimuli for this activation
include a variety of stress signals similar to those induced by
sustained passage of HDF (Patel et al., 2000). Consistent
with the finding that PKR is constitutively activated in high-
passage HDF, phosphorylation of eIF-2a on Ser51, the
residue targeted by activated PKR, was evident only in P10
HDF despite the ability to detect eIF-2a protein in most
cultures (Fig. 5B). It should be noted that infection with MV
or treatment with dsRNA further increased phosphorylation
of PKR above the elevated basal level detectable in high-
Fig. 4. High-passage HDFs exhibit increased sensitivity to dsRNA. Low
(P1)- and high (P10)-passage HDFs were subjected to various stress stimuli
and cell viability assessed at 12 h posttreatment by trypan blue exclusion
(A) or FACS detection of Annexin V staining (B). Stimuli included
infection with vMyxlac at MOI = 0.1 or 5, serum deprivation, and treatment
with LLnL (10 nM), staurosporine (STS, 50 nM), or poly(I:C) dsRNA (20
Ag/ml). Untreated cells served as a control. (A) Values represent the mean
number of trypan blue-positive cells F SD from triplicate wells as a
percentage of total cells. (B) Values represent the mean number of Annexin
V-positive/PI-negative cells F SD from duplicate samples that were.
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passage HDF these cells remained responsive to external
stimuli known to activate IFN responses.
Although STAT-1 protein levels did not vary signifi-
cantly with passage history, STAT-1 phosphorylated on
either Tyr701 or Ser727 was detected in high-passage HDF
but not in low-passage cells (Fig. 5B). Since phosphor-
ylation is a prerequisite for the activation of STAT-1 and its
subsequent translocation to the nucleus where it promotes
transcription of IFN-responsive genes, this finding sug-
gested that STAT-1 was also constitutively activated in high-
passage HDF. Immunofluorescence staining of STAT-1 in
high- and low-passage HDF confirmed this result. STAT-1
was detected primarily in the cytosol of P1 HDF, but was
abundant in the nucleus of P10 HDF in the absence of
exogenous stimuli where it colocalized with the nuclear
satin, DAPI (Fig. 5C).
Previous findings suggested that elements within the IFN
response pathway were constitutively upregulated and
activated in HDF as a result of sustained passage in vitro.
To determine whether these results correlated with increased
IFN production and biological activity, vesicular stomatitis
virus (VSV) plaque reduction assays were conducted using
CM from passaged HDF. VSV infection is extremelysensitive to the inhibitory effects of Type I IFN and
inhibition VSV replication remains the gold standard by
which IFN activity is determined (Julkunen et al., 1982).
Compared to untreated cells infected with VSV, pretreat-
ment with human IFN-h (5 U/ml) completely blocked VSV
replication and inhibited plaque formation in BHK cells
(Fig. 5D). Preincubation of BHK cells with CM from P1
and P3 HDF cultures had little impact on VSV plaque
formation, suggesting that little or no biologically active
IFN was being constitutively produced by these cells (Fig.
5D). In contrast, CM from high-passage HDF significantly
inhibited VSV replication, reducing plaque formation by
approximately 50% when CM from P10 HDF was used
(Fig. 5D). This effect was attributable to the activity of IFN
since CM pretreated with neutralizing antibodies to IFN-h,
but not IFN-a, failed to inhibit VSV replication (Fig. 5D).
These results suggest that repeated passage of HDF
upregulated IFN expression and resulted in constitutive
activation of the IFN response pathway and increased
sensitivity to stimuli that induce IFN responses, such as
dsRNA. However, it should be noted that low-passage
HDFs were not deficient in their ability to respond to stimuli
known to induce an IFN response. Treatment of P1 HDF
with poly(I:C) dsRNA induced or increased expression of
IFN-h, OAS, and PKR transcripts (Fig. 5A), activated PKR,
eIF-2a, and STAT-1a as determined by Western blot
detection of the phosphorylated forms of these proteins
(Fig. 5B) and promoted the production and release of IFN
capable of inhibiting VSV replication (Fig. 5D).
IFN neutralization promotes MV replication in
high-passage HDF
Given the potential link between the IFN and the
capacity for passaged HDF to support MV replication, the
effect of promoting or inhibiting IFN responses on MV
replication was investigated in low (P1)- and high (P10)-
passage cells. P1 HDF infected with vMyxlac in the
presence of poly(I:C) dsRNA retained the ability to
support foci formation (Fig. 6B) and productive infection
(Fig. 6H). However, the intensity of h-galactosidase
staining (Fig. 6G) and the magnitude of viral titers
obtained (Fig. 6H) were decreased relative to untreated
cells (Fig. 6A). The results of Fig. 5 demonstrated that the
IFN response pathway was activated in low-passage HDF
treated with dsRNA; thus, parallel experiments were
conducted in which cells were pretreated with poly(I:C)
dsRNA for 12 h prior to infection. Under these conditions,
both foci formation and viral titers were significantly
reduced (data not shown). In comparison, pretreatment of
P1 HDF with IFN-h completely blocked foci formation
(Fig. 6C) and abrogated viral replication (Fig. 6H). As
observed in high-passage cells infected with MV, individ-
ual h-galactosidase-positive cells were evident in IFN-
stimulated P1 cultures (Fig. 6C); thus, the block to MV
replication was at the level of viral spread.
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found to promote MV replication in otherwise nonsuppor-
tive high-passage HDF. Pretreatment of P10 cultures with
neutralizing antibodies to human IFN-h allowed MV to
spread and form foci (Fig. 6F) and replicate to titers
comparable to low-passage cells (Fig. 6H). Consistent with
the results of the VSV plaque reduction assays, inhibiting
the activity of IFN-a had only modest effects on MV
replication in high-passage HDF. Pretreatment with neutral-
izing antibodies to human IFN-a did not result in foci
formation or significant increases in late gene expression
(Figs. 6E and G) and did not allow MV to replicate to high
titers (Fig. 6H).Discussion
In the current study, we have demonstrated that MV, a
poxvirus commonly reported to be rabbit specific, has the
capacity to replicate in primary human fibroblasts in vitro.
This finding extends the observations of an earlier report
from our laboratory in which MV was also found to
productively infect a broad spectrum of human tumor cell
lines (Sypula et al., 2004) by demonstrating that IFN
responses following MV recognition and entry of primary
human cells significantly impact on the outcome of the
infection and are critical in determining the cell tropism of
the virus. Other recent studies have also indicated that MV
tropism in vitro is not restricted to leporine cells, suggesting
that the blockade to poxvirus infection in nontraditional host
species may be more circumventable than originally
suspected. For example, MV has been found to productively
infect several simian, murine, feline, and avian cell lines
(Comanita and Dekaban, 2004; Johnston et al., 2003; Wang
et al., 2004), a phenomenon that also can be linked to the
integrity of endogenous IFN responses in these cells.
However, it should be noted that MV has never been shown
to cause disease in humans or any vertebrate outside the
lagomorph family, but it can cause lethal infection in mice
deficient for STAT-1 (Wang et al., 2004).
The importance of the IFN family in controlling viral
infections is well established (Katze et al., 2002); thus, it is
not surprising that the antiviral effects mediated by these
cytokines can profoundly influence virus–host interactions.
Moreover, the current study indicates that host IFN
responses also have the potential to influence the inherent
permissiveness of cells from nonhost species to poxvirusFig. 5. The IFN response pathway is constitutively activated in high-passage HDF
serum-reduced media. After 24 h, cells were harvested for RNA and protein extrac
ml) served as a control. (A) RT-PCR detection of OAS, PKR, and IFNh expression
Western blot detection of unphosphorylated and phosphorylated STAT-1 (Tyr701, S
in each sample ensured equal loading. (C) Fluorescence microscopy detection
counterstain (blue). (D) Detection of relative IFN levels in CM from passaged HD
cells that were preincubated for 6 h with recombinant human IFNh instead of CM
cells using neutralizing antibodies directed against IFN-a (nIFNa) or IFN-h (nIF
Values represent mean number of plaques F SD in triplicate wells expressed asinfection. MV is predicted to encode immunomodulatory
proteins with the potential to target IFN responses mediated
by PKR (Barrett et al., 2001; Ramelot et al., 2002), but little
is known about the function of these proteins in the context
of MV infection let alone their efficacy in cells from nonhost
species. However, the results of this study and others (Wang
et al., 2004) demonstrating the importance of IFN in
permissiveness to MV infection would suggest that the
mechanisms employed by MV to counter these innate
responses are ineffective in nonpermissive cells. Given the
ability of MV to efficiently infect and replicate in rabbit
cells, including primary dermal fibroblasts analogous to the
human HDF used in the present study, this property is likely
species specific. For example, the MV IFN-g receptor
homologue M-T7 is specific for rabbit IFN-g while the
orthologs encoded by the orthopoxviruses have a much
broader species specificity (Alcami and Smith, 1996).
Because poxviruses typically exhibit a very restrictive host
range that has not been attributed to the presence or absence
of specific cell surface receptors necessary for virus
infection (Esposito and Fenner, 2001), these findings may
provide insight into a potential molecular basis for poxvirus
host and cell tropism.
Detection of phosphorylated PKR concurrent with
phosphorylated eIF-2a indicated that PKR was constitu-
tively activated in high-passage HDFs even in the absence
of external stimuli. It is likely that this finding represented
the activity of cellular regulators, such as PACT, which are
induced by differentiation and stress stimuli and activate
PKR leading to transcriptional shutdown (Patel and Sen,
1998; Patel et al., 2000). Yet it is less clear why activation of
PKR in high-passage HDF did not correlate with increased
apoptosis. High-passage HDFs remain sensitive to the
apoptosis induced by dsRNA since both MV infection and
treatment with poly(I:C) were associated with increased
cytotoxicity. However, we have observed decreased PARP
expression in primary HDFs as they are passaged (data not
shown), a phenomenon that has also been associated with
advanced fibroblast age in other studies (Ly et al., 2000).
Thus, it is conceivable that high-passage HDFs are more
resistant to the pro-apoptotic effects of sustained PKR
activation than low-passage cells in which PARP levels are
normal.
The current study also demonstrates the influence of age-
related effects on the susceptibility of cultured primary cells
to poxvirus infection. Changes in IFN production and
sensitivity as fibroblasts age in vitro have been well. HDFs were cultured for 1–10 passages then seeded at 80% confluence in
tion. Low-passage HDF (P1) stimulated with poly(I:C) dsRNA (DS, 20 Ag/
. Detection of GAPDH expression (lower panel) ensured equal loading. (B)
er727), PKR (Ser31), and eIF-2a (eIF-2a, Ser51). Detection of actin levels
of STAT-1a (green) in P1 and P10 HDF. Nuclei are indicated by DAPI
F by VSV plaque reduction assay. Untreated BHK21 cells () and BHK21
(hIFNh, 5 U/ml) served as controls. IFN was depleted from CM from P10
Nh). Cells were stained with crystal violet at 48 h PI to visualize plaques.
a percentage of plaques in untreated wells.
Fig. 6. Manipulation of the IFN response pathway alters the permissiveness of HDF. P1 and P10 HDFs were infected with vMyxlacZ at MOI = 0.1 in the
presence or absence of inducers and inhibitors of the IFN response. Infection was assessed by h-galactosidase assay at 48 h PI. (A–C) Infection of P1 HDF in
the presence of poly(I:C) dsRNA (B, 20 Ag/ml) or recombinant human IFNh (C, 5 U/ml) decreased MV replication compared to untreated cells (A). (D–F)
Pretreatment of P10 HDF with neutralizing antibodies to human IFNh (F, 100 NU/ml), but not human IFNa (E, 100 NU/ml) rendered cells permissive to MV
infection. (G) Quantification of h-galactosidase expression at 48 h PI. Values represent mean absorbance F SD (corrected for background) from triplicate
wells. (H) Viral titers obtained at 48 h PI. Values represent mean focus forming units F SD from triplicate wells.
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Lockart, 1968; Marcus and Carver, 1967; St. Geme and
Horrigan, 1969) and shown to involve IFN activity directly
at the level of individual cells rather than only reflect the
recruitment of more cells within the population to a state of
IFN sensitivity (Jordan and Merigan, 1974). Moreover, this
property has been associated with changes in susceptibility
to infection by viruses known to be exquisitely sensitive to
IFN, such as Newcastle disease virus and VSV (Jordan andMerigan, 1974; Lockart, 1968), and for poxviruses such as
Vaccinia virus (Gifford et al., 1963; Lindenmann and
Gifford, 1963). Since current poxvirus vaccination strategies
are contraindicated in those with compromised immune
systems, including young children and the elderly (Bennett
and Ledell, 2003), further investigation of role of IFN as a
determinant of poxvirus tropism may provide insight of use
to the development of safer vaccine strategies and the
development of novel antiviral agents directed at poxviruses.
J.B. Johnston et al. / Virology 332 (2005) 235–248 245IFN sensitivity also forms the basis for therapeutic
strategies utilizing viruses, such as the use of VSV as an
oncolytic agent (Stojdl et al., 2000). In that regard,
poxviruses are being widely investigated as platforms for
vaccine development, gene delivery, and oncolytic viral
therapies (Essajee and Kaufman, 2004; Guo and Bartlett,
2004; Thorne and Kirn, 2004). In the case of MV, the ability
to replicate productively in a majority of human tumor cells
tested (Sypula et al., 2004), but not in primary cells that
exhibit Type I IFN responses (this manuscript), suggests the
potential of MV as an oncolytic virus candidate. This
possibility is currently being tested in animal models of
human cancers.Materials and methods
Cells
Primary HDFs were derived from explant cultures of
neonatal foreskin tissue as described previously (Vilcek
et al., 1978) and grown in Dulbecco’s modified Eagle
medium (DMEM; GibcoBRL) completed with 10% fetal
bovine serum (Sigma), 100 units penicillin/ml, and 100
Ag streptomycin/ml. Briefly, foreskin tissue was obtained
from healthy neonates of less than 2 weeks of age
following elective circumcision conducted according to
standard surgical protocols. Tissue was finely minced and
individual explants were adhered to culture dishes to
stimulate spontaneous cell outgrowth. Explants were
cultured for 3 weeks in complete media to allow
maximal outgrowth, at which point rapidly replicating
HDFs were separated from slowly replicating human
epithelial cells (HEP) by low density passaging. Nested
RT-PCR detection of fibroblast-specific proline-4-hydrox-
ylase-a (P4Ha) expression in HDF cultures following
sustained passaging was used to confirm purity. Purified
HDFs were cultured between 1 and 10 passages to
achieve the desired level of maturity, amplified to
confluence, and stored in liquid nitrogen until used in
subsequent experiments. Primary RDFs were prepared in
the same manner using dermal tissue obtained from
healthy adult New Zealand White rabbits. Baby green
monkey kidney (BGMK) cells used to titrate infectious
virus and prepare virus stocks were also cultured in
complete DMEM.
Viruses and infection
Two derivatives of MV (strain Lausanne) that were
created by intergenic insertion of a marker cassette were
used for infection studies: vMyxlac, which contains a h-
galactosidase cassette driven by a late MV promoter, and
vMyxgfp, which contains a green fluorescent protein (GFP)
cassette driven by a synthetic Vaccinia virus early/late
promoter (Johnston et al., 2003). Both viruses werepropagated and titrated by focus formation on BGMK cells
as described previously (Opgenorth et al., 1992). For
infections, cells were incubated with either virus at the
indicated multiplicity of infection (MOI) for 1 h at 378C,
washed to remove excess virus, and cultured in complete
media according to experimental parameters. For growth
curve studies, cells were initially infected at MOI = 0.1
(multistep) or 5 (single-step) and cultured until harvested.
Harvested cells were subjected to three freeze–thaw cycles
followed by sonication to release cell-associated virus and
viral titers determined as above.
Cytotoxicity assays
High- and low-passage HDFs (2  104 cells/well) were
seeded in triplicate in 24-well plates and left untreated or
subjected to various stress stimuli. Stimuli included infec-
tion with vMyxlac at MOI = 0.1 or 5, serum deprivation,
and treatment with either the proteasome inhibitor N-
Acetyl-Leu-Leu-Norleu-al (LLnL; 10 nM), staurosporine
(STS, 50 nM), or poly(I:C) dsRNA (20 Ag/ml). Cell
viability was assessed at 12 h posttreatment by trypan blue
exclusion or Annexin V staining. For trypan blue assays,
cells were washed twice with phosphate-buffered saline
(PBS), then incubated at room temperature for 15 min in a
0.2% solution of trypan blue dye (Sigma) in PBS. Cells
were again washed with PBS and the percentage of viable
cells calculated as the number of cells that remained
impermeable to the dye divided by the total number of
cells. For Annexin V staining, duplicate aliquots of 1  105
cells were washed three times in PBS and resuspended in
100 Al of binding buffer (10 mM HEPES-NaOH, 140 mM
NaCl, 2.5 mM CaCl2). To each sample, 5 Al of FITC-
conjugated Annexin V (Pharmingen) and 2 Al of propidium
iodide (PI; Pharmingen) were added followed by incubation
at room temperature for 15 min. To control for nonspecific
binding, cell aliquots were incubated with Annexin V or PI
alone, while cells resuspended in binding buffer alone
served as negative controls. Stained cells were immediately
analyzed by flow cytometry using FACSCalibur and
CellQuest software (Becton Dickson).
b-Galactosidase staining and chromogenic assays
For h-galactosidase expression studies, cells infected
with vMyxlac were washed with phosphate-buffered saline
(PBS) at various time points postinfection (PI), fixed for 5
min in neutral-buffered formalin (3.7% formaldehyde in
PBS), and incubated for 4 h at 378C with X-gal staining
solution (100 Ag/ml X-gal, 500 AM potassium ferrocyanide,
and 200 AM MgCl2 in PBS). For each experimental
condition, the mean number of positive (blue) cells or foci
was counted in six high-powered fields from triplicate wells.
For chromogenic assays, 3  104 cells were seeded in 96-
well plates and infected with vMyxlac at the indicated MOI.
Infected cells were harvested at various time points PI,
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cycles. Fifty microliters of lysate from each sample was
transferred to triplicate wells of a 96-well plate and
incubated at 378C for 5 min with 110 Al of reducing buffer
(100 mM NaH2PO4, 10 mM KCL, 1 mM MgSO4, 50 mM
h-mercaptoethanol). Reduced samples were further incu-
bated with 50 Al o-nitrophenyl-h-d-galactopyranoside
(ONGP) substrate for 10 min at 378C and h-galactosidase
activity measured by detection of ONGP cleavage at 415 nm
using a standard plate reader.
Reverse transcriptase (RT)-PCR analyses
Total cellular RNAwas isolated from cultured cells using
a RNAeasy Mini Kit (Qiagen) and DNAse treated for 30
min at 378C. cDNA was prepared using Superscript II RT
(Invitrogen) and amplified by 1 cycle (958C for 1 min), 30
cycles (958C for 1 min, 558C for 1 min, 728C for 2 min),
and 1 cycle (728C for 10 min) with primers specific for each
transcript. Primers used included: 5V-acc ttg act gtg tgg aag
aaa agc-3Vand 5V-aac aaa gag atg agg ctg ggc g-3V(PKR), 5V-
tgt gtg tgt gtc caa ggt ggt aaa g-3Vand 5V-gaa gtc tct ctg tag
ttc tgt gaa gca g-3V(OAS), 5V-gac agg agg aac ttt gac atc cc-
3Vand 5V-act ctg act atg gtc cag gca cag-3V(IFNh), and 5V-gat
ggg gca ggg gat gtt gac gac-3Vand 5V-gcg gga ggg acg cag
cga gac t-3V(P4Ha). Loading of equal amounts of template
cDNA was assessed by amplification of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) at an annealing tem-
perature of 508C using primers 5V-agc ctt ctc cat ggt ggt gaa
gac-3Vand 5V-cgg agt caa cgg att tgg tcg-3V. Amplification of
DNAse-treated RNA obtained from each sample prior to
reverse transcription served as controls to ensure the lack of
contaminating DNA. PCR products were separated by
agarose gel electrophoresis and visualized by ethidium
bromide staining.
Immunoblot analysis
Cultured cells were lysed in buffer containing 10 mM
Tris, pH 4.0, 10 mM NaCl, 3 mM MgCl2, and 0.5% Tween
20, sonicated to solubilize proteins, and cleared by
centrifugation. Protein levels were quantified using a protein
assay kit (BIO-RAD) and 25 Ag of each sample separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Separated proteins were transferred to nitrocellulose and
blocked with 5% bovine serum albumin (BSA) in TBST (25
mM Tris-buffered saline, 0.5% Tween 20). Primary anti-
bodies were diluted in 1% BSA-TBST and incubated with
membranes for 1 h at room temperature. Membranes were
washed and incubated for 1 h at room temperature with
horseradish peroxidase-conjugated secondary antibodies
diluted 1:3000 in 1% BSA-TBST. Immunoreactive proteins
were detected by chemiluminescence (Perkin-Elmer). Load-
ing of equal amounts of protein from each sample was
confirmed by detection of the housekeeping gene actin.
Mouse monoclonal antibodies specific for actin and STAT-1a were obtained from Santa Cruz Biotechnology Inc, while
rabbit polyclonal antibodies specific for STAT-1 phosphory-
lated at Tyr701 or Ser727 were obtained from Upstate
Biotechnology. Rabbit polyclonal antibodies specific for
PKR, pPKR (Thr451), eIF-2a, and peIF-2a (Ser51) were
obtained from Cell Signaling Technology. Horseradish
peroxidase (HRP)-conjugated goat-anti-mouse and goat-
anti-rabbit secondary antibodies were obtained from Jack-
son ImmunoResearch Laboratories Inc.
Immunofluorescence staining and fluorescence microscopy
HDFs were seeded on coverslips coated with poly-l-
lysine (Sigma), grown to 80% confluence, and then fixed
and permeabilized by incubation with ice-cold methanol for
10 min at 48C. Fixed cells were washed with PBS and
incubated with blocking buffer (10% normal goat serum in
PBS) at room temperature for 1 h. Cells were washed with
PBS, incubated for 1 h at room temperature with mono-
clonal antibody specific for human STAT-1a (Santa Cruz
Biotechnology Inc) diluted 1:100 dilution in blocking
buffer, then washed again in PBS before being incubated
for 1 h at room temperature with FITC-conjugated goat-
anti-mouse secondary antibody (Jackson ImmunoResearch
Laboratories Inc) diluted 1:500 in blocking buffer. After
three washes in PBS, cells were counterstained with DAPI
reagent (Molecular Probes) for 5 min at 48C to visualize
nuclei. Coverslips were mounted onto glass slides using
Prolong Antifade medium (Molecular Probes) to reduce
photobleaching and examined by fluorescence microscopy
using FITC, brightfield, or DAPI filters. In all immunos-
taining experiments, isotype control antibodies were used
to control for nonspecific antibody binding.
VSV plaque reduction assay
HDF (2  105 cells/well) of the indicated passage
history were seeded in 12-well plates in serum-reduced
medium containing or lacking poly(I:C) dsRNA (20 Ag/
ml; Sigma). After 24 h, conditioned media (CM) were
harvested, cleared by centrifugation, and diluted 1:5 with
serum-reduced medium. Subconfluent BHK21 cells were
preincubated for 6 h at 378C with human IFNh (5 U/
ml; BioSource International Inc) or 1 ml of the diluted
CM, washed once with PBS, then infected with 25 pfu
of vesicular stomatitis virus (VSV). VSV was adsorbed
for 1 h at 378C, at which point the inoculum was
removed and cells overlayed with a 60:40 mixture of
DMEM and 1% agarose. Infected cells were incubated
at 378C for 48 h and plaques were visualized by crystal
violet staining (0.07% crystal violet and 5.5% form-
aldehyde in PBS). To confirm that IFN was responsible
for any reduction in plaque formation observed, CM
from P10 HDF was pretreated with 100 NU/ml of
neutralizing antibodies against either human IFN-a or
IFN-h (BioSource International Inc).
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